文献速递先天性心脏病外科心外重症与机械循环支持

PediMag与CentriMag用于右侧衰竭Fontan循环的体外分析

An in vitro analysis of the PediMag and CentriMag for right-sided failing Fontan support.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-04-26

本研究利用Compliance匹配、患者特异性全腔静脉肺动脉连接体外模型,建立衰竭Fontan基线血流动力学(心输出量3.5 L/min、中心静脉压约17 mm Hg),评估PediMag与CentriMag改善衰竭Fontan血流动力学的能力。结果显示,PediMag需完全限制Fontan通路,使下腔静脉压降低约10 mm Hg、心输出量增至5 L/min,但上腔静脉压升高约6 mm Hg;CentriMag产生类似血流动力学改变,且无需通路限制或上腔静脉压升高。

要点

  • PediMag需完全限制Fontan通路,下腔静脉压降约10 mm Hg,心输出量增至5 L/min,上腔静脉压升约6 mm Hg。
  • CentriMag无需通路限制即可降低下腔静脉压并增加心输出量,且不升高上腔静脉压。
  • 体外模型结果为Fontan辅助装置优化设计提供数据,但尚需临床验证。

核心结论

  • PediMag与CentriMag右侧支持均可降低下腔静脉压并增加心输出量,CentriMag无需通路限制且不升高上腔静脉压。

研究设计与样本

  • 体外研究:将PediMag与CentriMag分别连接至Compliance匹配、患者特异性全腔静脉肺动脉连接体外模型。
  • 模型使用电阻、Compliance及可编程波形建立衰竭Fontan基线血流动力学(心输出量3.5 L/min、中心静脉压约17 mm Hg)。

主要发现

  • PediMag需完全限制Fontan通路,使下腔静脉压降低约10 mm Hg,心输出量增至5 L/min,上腔静脉压升高约6 mm Hg。
  • CentriMag产生类似血流动力学改变,无需通路限制,且不升高上腔静脉压。

临床怎么用

  • CentriMag在体外模型中无需限制Fontan通路即可改善血流动力学,或可简化衰竭Fontan的右侧机械循环支持策略。
  • PediMag需完全限制Fontan通路且升高上腔静脉压,临床应用时需权衡其血流动力学代价。

局限性

  • 本研究为体外模型研究,结果不能直接等同于临床疗效与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Right-sided mechanical circulatory support for failing Fontan physiology has been largely unsuccessful due to inherent hemodynamic differences between these patients and the target populations for most assist devices. This study uses advanced benchtop modeling of Fontan physiology to examine the use of PediMag and CentriMag to improve failing Fontan hemodynamics. METHODS: Each device was attached to a compliance-matched, patient-specific total cavopulmonary connection in vitro model that used resistances, compliances, and programmable waveforms to establish "failing Fontan" baseline hemodynamics (cardiac output [CO] = 3.5 L/min and central venous pressure ∼17 mm Hg). The ability of the assist devices to improve failing Fontan hemodynamics (reduce inferior vena cava pressure and augment CO) was investigated. RESULTS: Requiring complete Fontan pathway restriction, PediMag reduced inferior vena cava pressure by ∼10 mm Hg and supported CO augmentation up to 5 L/min. This was accompanied by an increase in superior vena cava pressure of ∼6 mm Hg. CentriMag produced similar hemodynamic changes without the need for pathway restriction or an increase in superior vena cava pressure. CONCLUSIONS: PediMag and CentriMag right-sided support led to a decrease in inferior vena cava pressure and augmentation of cardiac output. In the case of CentriMag, this is accomplished without an increase in superior vena cava pressure or the need for restrictive banding. This work provides further data to help with the optimal design of a Fontan assist device to ameliorate the growing need.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Trusty PM, Tree M, Maher K, et al. An in vitro analysis of the PediMag and CentriMag for right-sided failing Fontan support. J Thorac Cardiovasc Surg. 2019. PMID: 31133353. doi:10.1016/j.jtcvs.2019.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。